Global Bevacizumab Monoclonal Antibody Biosimilar Supply, Demand and Key Producers, 2023-2029
The global Bevacizumab Monoclonal Antibody Biosimilar market size is expected to reach $ 484.9 million by 2029, rising at a market growth of -13.9% CAGR during the forecast period (2023-2029).
Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood vessels in tumours and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.
This report studies the global Bevacizumab Monoclonal Antibody Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Bevacizumab Monoclonal Antibody Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bevacizumab Monoclonal Antibody Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Bevacizumab Monoclonal Antibody Biosimilar total production and demand, 2018-2029, (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar total production value, 2018-2029, (USD Million)
Global Bevacizumab Monoclonal Antibody Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Bevacizumab Monoclonal Antibody Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Bevacizumab Monoclonal Antibody Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Bevacizumab Monoclonal Antibody Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Celltrion, Amneal, Pfizer and Amgen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bevacizumab Monoclonal Antibody Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Bevacizumab Monoclonal Antibody Biosimilar Market, By Region:
1. How big is the global Bevacizumab Monoclonal Antibody Biosimilar market?
2. What is the demand of the global Bevacizumab Monoclonal Antibody Biosimilar market?
3. What is the year over year growth of the global Bevacizumab Monoclonal Antibody Biosimilar market?
4. What is the production and production value of the global Bevacizumab Monoclonal Antibody Biosimilar market?
5. Who are the key producers in the global Bevacizumab Monoclonal Antibody Biosimilar market?
6. What are the growth factors driving the market demand?
Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood vessels in tumours and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.
This report studies the global Bevacizumab Monoclonal Antibody Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Bevacizumab Monoclonal Antibody Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bevacizumab Monoclonal Antibody Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Bevacizumab Monoclonal Antibody Biosimilar total production and demand, 2018-2029, (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar total production value, 2018-2029, (USD Million)
Global Bevacizumab Monoclonal Antibody Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Bevacizumab Monoclonal Antibody Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Bevacizumab Monoclonal Antibody Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Bevacizumab Monoclonal Antibody Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Bevacizumab Monoclonal Antibody Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Celltrion, Amneal, Pfizer and Amgen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bevacizumab Monoclonal Antibody Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Bevacizumab Monoclonal Antibody Biosimilar Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 400mg
- 100mg
- Cancer
- Wet Age-related Macular Degeneration
- Other
- Celltrion
- Amneal
- Pfizer
- Amgen
1. How big is the global Bevacizumab Monoclonal Antibody Biosimilar market?
2. What is the demand of the global Bevacizumab Monoclonal Antibody Biosimilar market?
3. What is the year over year growth of the global Bevacizumab Monoclonal Antibody Biosimilar market?
4. What is the production and production value of the global Bevacizumab Monoclonal Antibody Biosimilar market?
5. Who are the key producers in the global Bevacizumab Monoclonal Antibody Biosimilar market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Bevacizumab Monoclonal Antibody Biosimilar Introduction
1.2 World Bevacizumab Monoclonal Antibody Biosimilar Supply & Forecast
1.2.1 World Bevacizumab Monoclonal Antibody Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.2.3 World Bevacizumab Monoclonal Antibody Biosimilar Pricing Trends (2018-2029)
1.3 World Bevacizumab Monoclonal Antibody Biosimilar Production by Region (Based on Production Site)
1.3.1 World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Region (2018-2029)
1.3.2 World Bevacizumab Monoclonal Antibody Biosimilar Production by Region (2018-2029)
1.3.3 World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.5 Europe Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.6 China Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.7 Japan Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Bevacizumab Monoclonal Antibody Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Bevacizumab Monoclonal Antibody Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Bevacizumab Monoclonal Antibody Biosimilar Demand (2018-2029)
2.2 World Bevacizumab Monoclonal Antibody Biosimilar Consumption by Region
2.2.1 World Bevacizumab Monoclonal Antibody Biosimilar Consumption by Region (2018-2023)
2.2.2 World Bevacizumab Monoclonal Antibody Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.4 China Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.5 Europe Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.6 Japan Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.7 South Korea Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.8 ASEAN Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.9 India Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
3 WORLD BEVACIZUMAB MONOCLONAL ANTIBODY BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Bevacizumab Monoclonal Antibody Biosimilar Production by Manufacturer (2018-2023)
3.3 World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Bevacizumab Monoclonal Antibody Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Bevacizumab Monoclonal Antibody Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Bevacizumab Monoclonal Antibody Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Bevacizumab Monoclonal Antibody Biosimilar in 2022
3.6 Bevacizumab Monoclonal Antibody Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Bevacizumab Monoclonal Antibody Biosimilar Market: Region Footprint
3.6.2 Bevacizumab Monoclonal Antibody Biosimilar Market: Company Product Type Footprint
3.6.3 Bevacizumab Monoclonal Antibody Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Value Comparison
4.1.1 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Comparison
4.2.1 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Consumption Comparison
4.3.1 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023)
4.5 China Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers and Market Share
4.5.1 China Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023)
4.6 Rest of World Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Bevacizumab Monoclonal Antibody Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 400mg
5.2.2 100mg
5.3 Market Segment by Type
5.3.1 World Bevacizumab Monoclonal Antibody Biosimilar Production by Type (2018-2029)
5.3.2 World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Type (2018-2029)
5.3.3 World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Bevacizumab Monoclonal Antibody Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Wet Age-related Macular Degeneration
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Bevacizumab Monoclonal Antibody Biosimilar Production by Application (2018-2029)
6.3.2 World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Application (2018-2029)
6.3.3 World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Celltrion
7.1.1 Celltrion Details
7.1.2 Celltrion Major Business
7.1.3 Celltrion Bevacizumab Monoclonal Antibody Biosimilar Product and Services
7.1.4 Celltrion Bevacizumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Celltrion Recent Developments/Updates
7.1.6 Celltrion Competitive Strengths & Weaknesses
7.2 Amneal
7.2.1 Amneal Details
7.2.2 Amneal Major Business
7.2.3 Amneal Bevacizumab Monoclonal Antibody Biosimilar Product and Services
7.2.4 Amneal Bevacizumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amneal Recent Developments/Updates
7.2.6 Amneal Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Bevacizumab Monoclonal Antibody Biosimilar Product and Services
7.3.4 Pfizer Bevacizumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Amgen
7.4.1 Amgen Details
7.4.2 Amgen Major Business
7.4.3 Amgen Bevacizumab Monoclonal Antibody Biosimilar Product and Services
7.4.4 Amgen Bevacizumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Amgen Recent Developments/Updates
7.4.6 Amgen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Bevacizumab Monoclonal Antibody Biosimilar Industry Chain
8.2 Bevacizumab Monoclonal Antibody Biosimilar Upstream Analysis
8.2.1 Bevacizumab Monoclonal Antibody Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Bevacizumab Monoclonal Antibody Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Bevacizumab Monoclonal Antibody Biosimilar Production Mode
8.6 Bevacizumab Monoclonal Antibody Biosimilar Procurement Model
8.7 Bevacizumab Monoclonal Antibody Biosimilar Industry Sales Model and Sales Channels
8.7.1 Bevacizumab Monoclonal Antibody Biosimilar Sales Model
8.7.2 Bevacizumab Monoclonal Antibody Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Bevacizumab Monoclonal Antibody Biosimilar Introduction
1.2 World Bevacizumab Monoclonal Antibody Biosimilar Supply & Forecast
1.2.1 World Bevacizumab Monoclonal Antibody Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.2.3 World Bevacizumab Monoclonal Antibody Biosimilar Pricing Trends (2018-2029)
1.3 World Bevacizumab Monoclonal Antibody Biosimilar Production by Region (Based on Production Site)
1.3.1 World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Region (2018-2029)
1.3.2 World Bevacizumab Monoclonal Antibody Biosimilar Production by Region (2018-2029)
1.3.3 World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.5 Europe Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.6 China Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.3.7 Japan Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Bevacizumab Monoclonal Antibody Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Bevacizumab Monoclonal Antibody Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Bevacizumab Monoclonal Antibody Biosimilar Demand (2018-2029)
2.2 World Bevacizumab Monoclonal Antibody Biosimilar Consumption by Region
2.2.1 World Bevacizumab Monoclonal Antibody Biosimilar Consumption by Region (2018-2023)
2.2.2 World Bevacizumab Monoclonal Antibody Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.4 China Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.5 Europe Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.6 Japan Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.7 South Korea Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.8 ASEAN Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
2.9 India Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029)
3 WORLD BEVACIZUMAB MONOCLONAL ANTIBODY BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Bevacizumab Monoclonal Antibody Biosimilar Production by Manufacturer (2018-2023)
3.3 World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Bevacizumab Monoclonal Antibody Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Bevacizumab Monoclonal Antibody Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Bevacizumab Monoclonal Antibody Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Bevacizumab Monoclonal Antibody Biosimilar in 2022
3.6 Bevacizumab Monoclonal Antibody Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Bevacizumab Monoclonal Antibody Biosimilar Market: Region Footprint
3.6.2 Bevacizumab Monoclonal Antibody Biosimilar Market: Company Product Type Footprint
3.6.3 Bevacizumab Monoclonal Antibody Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Value Comparison
4.1.1 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Comparison
4.2.1 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Consumption Comparison
4.3.1 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023)
4.5 China Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers and Market Share
4.5.1 China Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023)
4.6 Rest of World Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Bevacizumab Monoclonal Antibody Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 400mg
5.2.2 100mg
5.3 Market Segment by Type
5.3.1 World Bevacizumab Monoclonal Antibody Biosimilar Production by Type (2018-2029)
5.3.2 World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Type (2018-2029)
5.3.3 World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Bevacizumab Monoclonal Antibody Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Wet Age-related Macular Degeneration
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Bevacizumab Monoclonal Antibody Biosimilar Production by Application (2018-2029)
6.3.2 World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Application (2018-2029)
6.3.3 World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Celltrion
7.1.1 Celltrion Details
7.1.2 Celltrion Major Business
7.1.3 Celltrion Bevacizumab Monoclonal Antibody Biosimilar Product and Services
7.1.4 Celltrion Bevacizumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Celltrion Recent Developments/Updates
7.1.6 Celltrion Competitive Strengths & Weaknesses
7.2 Amneal
7.2.1 Amneal Details
7.2.2 Amneal Major Business
7.2.3 Amneal Bevacizumab Monoclonal Antibody Biosimilar Product and Services
7.2.4 Amneal Bevacizumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amneal Recent Developments/Updates
7.2.6 Amneal Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Bevacizumab Monoclonal Antibody Biosimilar Product and Services
7.3.4 Pfizer Bevacizumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Amgen
7.4.1 Amgen Details
7.4.2 Amgen Major Business
7.4.3 Amgen Bevacizumab Monoclonal Antibody Biosimilar Product and Services
7.4.4 Amgen Bevacizumab Monoclonal Antibody Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Amgen Recent Developments/Updates
7.4.6 Amgen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Bevacizumab Monoclonal Antibody Biosimilar Industry Chain
8.2 Bevacizumab Monoclonal Antibody Biosimilar Upstream Analysis
8.2.1 Bevacizumab Monoclonal Antibody Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Bevacizumab Monoclonal Antibody Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Bevacizumab Monoclonal Antibody Biosimilar Production Mode
8.6 Bevacizumab Monoclonal Antibody Biosimilar Procurement Model
8.7 Bevacizumab Monoclonal Antibody Biosimilar Industry Sales Model and Sales Channels
8.7.1 Bevacizumab Monoclonal Antibody Biosimilar Sales Model
8.7.2 Bevacizumab Monoclonal Antibody Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Bevacizumab Monoclonal Antibody Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Bevacizumab Monoclonal Antibody Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Bevacizumab Monoclonal Antibody Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Bevacizumab Monoclonal Antibody Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Bevacizumab Monoclonal Antibody Biosimilar Major Market Trends
Table 13. World Bevacizumab Monoclonal Antibody Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Bevacizumab Monoclonal Antibody Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Bevacizumab Monoclonal Antibody Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Bevacizumab Monoclonal Antibody Biosimilar Producers in 2022
Table 18. World Bevacizumab Monoclonal Antibody Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Bevacizumab Monoclonal Antibody Biosimilar Producers in 2022
Table 20. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Bevacizumab Monoclonal Antibody Biosimilar Company Evaluation Quadrant
Table 22. World Bevacizumab Monoclonal Antibody Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Bevacizumab Monoclonal Antibody Biosimilar Production Site of Key Manufacturer
Table 24. Bevacizumab Monoclonal Antibody Biosimilar Market: Company Product Type Footprint
Table 25. Bevacizumab Monoclonal Antibody Biosimilar Market: Company Product Application Footprint
Table 26. Bevacizumab Monoclonal Antibody Biosimilar Competitive Factors
Table 27. Bevacizumab Monoclonal Antibody Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Bevacizumab Monoclonal Antibody Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Bevacizumab Monoclonal Antibody Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Bevacizumab Monoclonal Antibody Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Bevacizumab Monoclonal Antibody Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 37. China Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 47. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Bevacizumab Monoclonal Antibody Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Bevacizumab Monoclonal Antibody Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Bevacizumab Monoclonal Antibody Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Bevacizumab Monoclonal Antibody Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Celltrion Basic Information, Manufacturing Base and Competitors
Table 62. Celltrion Major Business
Table 63. Celltrion Bevacizumab Monoclonal Antibody Biosimilar Product and Services
Table 64. Celltrion Bevacizumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Celltrion Recent Developments/Updates
Table 66. Celltrion Competitive Strengths & Weaknesses
Table 67. Amneal Basic Information, Manufacturing Base and Competitors
Table 68. Amneal Major Business
Table 69. Amneal Bevacizumab Monoclonal Antibody Biosimilar Product and Services
Table 70. Amneal Bevacizumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amneal Recent Developments/Updates
Table 72. Amneal Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Bevacizumab Monoclonal Antibody Biosimilar Product and Services
Table 76. Pfizer Bevacizumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Amgen Basic Information, Manufacturing Base and Competitors
Table 79. Amgen Major Business
Table 80. Amgen Bevacizumab Monoclonal Antibody Biosimilar Product and Services
Table 81. Amgen Bevacizumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Global Key Players of Bevacizumab Monoclonal Antibody Biosimilar Upstream (Raw Materials)
Table 83. Bevacizumab Monoclonal Antibody Biosimilar Typical Customers
Table 84. Bevacizumab Monoclonal Antibody Biosimilar Typical Distributors
Table 1. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Bevacizumab Monoclonal Antibody Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Bevacizumab Monoclonal Antibody Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Bevacizumab Monoclonal Antibody Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Bevacizumab Monoclonal Antibody Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Bevacizumab Monoclonal Antibody Biosimilar Major Market Trends
Table 13. World Bevacizumab Monoclonal Antibody Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Bevacizumab Monoclonal Antibody Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Bevacizumab Monoclonal Antibody Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Bevacizumab Monoclonal Antibody Biosimilar Producers in 2022
Table 18. World Bevacizumab Monoclonal Antibody Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Bevacizumab Monoclonal Antibody Biosimilar Producers in 2022
Table 20. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Bevacizumab Monoclonal Antibody Biosimilar Company Evaluation Quadrant
Table 22. World Bevacizumab Monoclonal Antibody Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Bevacizumab Monoclonal Antibody Biosimilar Production Site of Key Manufacturer
Table 24. Bevacizumab Monoclonal Antibody Biosimilar Market: Company Product Type Footprint
Table 25. Bevacizumab Monoclonal Antibody Biosimilar Market: Company Product Application Footprint
Table 26. Bevacizumab Monoclonal Antibody Biosimilar Competitive Factors
Table 27. Bevacizumab Monoclonal Antibody Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Bevacizumab Monoclonal Antibody Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Bevacizumab Monoclonal Antibody Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Bevacizumab Monoclonal Antibody Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Bevacizumab Monoclonal Antibody Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 37. China Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Bevacizumab Monoclonal Antibody Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share (2018-2023)
Table 47. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Bevacizumab Monoclonal Antibody Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Bevacizumab Monoclonal Antibody Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Bevacizumab Monoclonal Antibody Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Bevacizumab Monoclonal Antibody Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Celltrion Basic Information, Manufacturing Base and Competitors
Table 62. Celltrion Major Business
Table 63. Celltrion Bevacizumab Monoclonal Antibody Biosimilar Product and Services
Table 64. Celltrion Bevacizumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Celltrion Recent Developments/Updates
Table 66. Celltrion Competitive Strengths & Weaknesses
Table 67. Amneal Basic Information, Manufacturing Base and Competitors
Table 68. Amneal Major Business
Table 69. Amneal Bevacizumab Monoclonal Antibody Biosimilar Product and Services
Table 70. Amneal Bevacizumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amneal Recent Developments/Updates
Table 72. Amneal Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Bevacizumab Monoclonal Antibody Biosimilar Product and Services
Table 76. Pfizer Bevacizumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Amgen Basic Information, Manufacturing Base and Competitors
Table 79. Amgen Major Business
Table 80. Amgen Bevacizumab Monoclonal Antibody Biosimilar Product and Services
Table 81. Amgen Bevacizumab Monoclonal Antibody Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Global Key Players of Bevacizumab Monoclonal Antibody Biosimilar Upstream (Raw Materials)
Table 83. Bevacizumab Monoclonal Antibody Biosimilar Typical Customers
Table 84. Bevacizumab Monoclonal Antibody Biosimilar Typical Distributors
LIST OF FIGURES
Figure 1. Bevacizumab Monoclonal Antibody Biosimilar Picture
Figure 2. World Bevacizumab Monoclonal Antibody Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Bevacizumab Monoclonal Antibody Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Bevacizumab Monoclonal Antibody Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Bevacizumab Monoclonal Antibody Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 12. Bevacizumab Monoclonal Antibody Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Bevacizumab Monoclonal Antibody Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Bevacizumab Monoclonal Antibody Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Bevacizumab Monoclonal Antibody Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Bevacizumab Monoclonal Antibody Biosimilar Markets in 2022
Figure 26. United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 32. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Type in 2022
Figure 34. 400mg
Figure 35. 100mg
Figure 36. World Bevacizumab Monoclonal Antibody Biosimilar Production Market Share by Type (2018-2029)
Figure 37. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Type (2018-2029)
Figure 38. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Application in 2022
Figure 41. Cancer
Figure 42. Wet Age-related Macular Degeneration
Figure 43. Other
Figure 44. World Bevacizumab Monoclonal Antibody Biosimilar Production Market Share by Application (2018-2029)
Figure 45. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Application (2018-2029)
Figure 46. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Bevacizumab Monoclonal Antibody Biosimilar Industry Chain
Figure 48. Bevacizumab Monoclonal Antibody Biosimilar Procurement Model
Figure 49. Bevacizumab Monoclonal Antibody Biosimilar Sales Model
Figure 50. Bevacizumab Monoclonal Antibody Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Bevacizumab Monoclonal Antibody Biosimilar Picture
Figure 2. World Bevacizumab Monoclonal Antibody Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Bevacizumab Monoclonal Antibody Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Bevacizumab Monoclonal Antibody Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Bevacizumab Monoclonal Antibody Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Bevacizumab Monoclonal Antibody Biosimilar Production (2018-2029) & (K Units)
Figure 12. Bevacizumab Monoclonal Antibody Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Bevacizumab Monoclonal Antibody Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Bevacizumab Monoclonal Antibody Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Bevacizumab Monoclonal Antibody Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Bevacizumab Monoclonal Antibody Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Bevacizumab Monoclonal Antibody Biosimilar Markets in 2022
Figure 26. United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Bevacizumab Monoclonal Antibody Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Bevacizumab Monoclonal Antibody Biosimilar Production Market Share 2022
Figure 32. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Type in 2022
Figure 34. 400mg
Figure 35. 100mg
Figure 36. World Bevacizumab Monoclonal Antibody Biosimilar Production Market Share by Type (2018-2029)
Figure 37. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Type (2018-2029)
Figure 38. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Bevacizumab Monoclonal Antibody Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Application in 2022
Figure 41. Cancer
Figure 42. Wet Age-related Macular Degeneration
Figure 43. Other
Figure 44. World Bevacizumab Monoclonal Antibody Biosimilar Production Market Share by Application (2018-2029)
Figure 45. World Bevacizumab Monoclonal Antibody Biosimilar Production Value Market Share by Application (2018-2029)
Figure 46. World Bevacizumab Monoclonal Antibody Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Bevacizumab Monoclonal Antibody Biosimilar Industry Chain
Figure 48. Bevacizumab Monoclonal Antibody Biosimilar Procurement Model
Figure 49. Bevacizumab Monoclonal Antibody Biosimilar Sales Model
Figure 50. Bevacizumab Monoclonal Antibody Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
